Skip to main content
Fig. 4 | Molecular Cancer

Fig. 4

From: MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumors

Fig. 4

Box-plots and ROC curves of miR-34b/c, miR-193b and miR-1258 promoter methylation levels across urine sediments of controls (HD) and prostate cancer patients (PCa) from Cohort #3. Receiver operator characteristic (ROC) curves were constructed to evaluate the performance of the gene promoter methylation panel (miR-34b/c+miR-193b)

Back to article page

Molecular Cancer

ISSN: 1476-4598